Skip to main content

Table 1 Participant characteristics at baseline by sex and incident dementia status in the UK Biobank

From: Ideal vitamin D and handgrip strength counteracts the risk effect of APOE genotype on dementia: a population-based longitudinal study

Characteristic

Women

Men

All women

Women who developed dementia

All men

Men who developed dementia

Number of participants, n (%)

84,610 (97.9)

1778 (2.1)

81,078 (97.4)

2139 (2.6)

Age, mean (SD), year

64.0 (2.8)

65.8 (2.7)

64.2 (2.9)

65.8 (2.7)

Ethnicity, n (%)

 White

82,300 (97.3)

1723 (96.9)

78,890 (97.3)

2057 (96.2)

 Asian

264 (0.3)

5 (0.3)

204 (0.3)

8 (0.4)

 Black

780 (0.9)

16 (0.9)

1036 (1.3)

33 (1.5)

 Other

1266 (1.5)

34 (1.9)

948 (1.1)

41 (1.9)

Education level, n (%)

 College or University

19,949 (23.6)

303 (17.0)

23,716 (29.3)

493 (23.0)

 Upper secondary

7911 (9.3)

151 (8.5)

6990 (8.6)

174 (8.1)

 Lower secondary

22,752 (26.9)

431 (24.2)

15,854 (19.6)

360 (16.8)

 Vocational

3635 (4.3)

66 (3.7)

8568 (10.6)

242 (11.3)

 Other

30,363 (35.9)

827 (46.5)

25,950 (32.0)

870 (40.7)

Socioeconomic status, n (%)

 High

30,104 (35.6)

534 (30.0)

29,933 (36.9)

700 (32.7)

 Middle

29,499 (34.9)

564 (31.7)

27,667 (34.1)

715 (33.4)

 Low

25,007 (29.6)

680 (38.2)

23,478 (29.0)

724 (33.8)

Moderate alcohol consumption, n (%)

45,434 (53.7)

842 (47.4)

48,915 (60.3)

1,224 (57.2)

Smoking status, n (%)

 Never

48,461 (57.3)

938 (52.8)

33,959 (41.9)

798 (37.3)

 Former

30,537 (36.1)

687 (38.6)

39,164 (48.3)

1114 (52.1)

 Current

5612 (6.6)

153 (8.6)

7955 (9.8)

227 (10.6)

Grip strength, mean (SD), nmol/L

21.3 (5.7)

19.7 (5.8)

37.2 (8.1)

34.3 (8.2)

Grip strength, n (%)

 Low

37,425 (44.2)

990 (55.7)

33,886 (41.8)

1187 (55.5)

 Middle

31,432 (37.1)

570 (32.1)

29,770 (36.7)

676 (31.6)

 High

15,753 (18.6)

218 (12.3)

17,422 (21.5)

276 (12.9)

BMI, mean (SD), kg/m2

27.3 (4.9)

27.6 (5.4)

27.9 (4.1)

27.9 (4.4)

BMI, n (%)

    

 Normal weight

29,567 (34.9)

609 (34.3)

18,873 (23.3)

545 (25.5)

 Overweight

34,020 (40.2)

688 (38.7)

41,381 (51.0)

995 (46.5)

 Obesity

21,023 (24.8)

481 (27.1)

20,824 (25.7)

599 (28.0)

Heart disease, n (%)

3136 (3.7)

159 (8.9)

8795 (10.8)

391 (18.3)

Stroke, n (%)

1567 (1.9)

72 (4.0)

2525 (3.1)

157 (7.3)

Hypertension, n (%)

39,194 (46.3)

943 (53.0)

44,875 (55.3)

1270 (59.4)

Diabetes, n (%)

4295 (5.1)

195 (11.0)

7547 (9.3)

377 (17.6)

Depression, n (%)

677 (0.8)

39 (2.2)

517 (0.6)

30 (1.4)

TC, mean (SD), mmol/L

7.3 (9.4)

6.7 (7.4)

6.5 (8.9)

5.9 (7.5)

HDL, mean (SD), mmol/L

1.6 (0.6)

1.6 (0.6)

1.3 (0.5)

1.3 (0.6)

LDL, mean (SD), mmol/L

5.7 (11.4)

5.5 (11.12)

5.1 (10.6)

4.3 (8.8)

Vitamin D, mean (SD), nmol/L

50.5 (20.3)

47.5 (20.5)

51.5 (20.8)

48.8 (21.2)

Vitamin D, n (%)

 Low

27,528 (32.5)

696 (39.1)

25,297 (31.2)

821 (38.4)

 Middle

22,374 (26.4)

453 (25.5)

21,163 (26.1)

526 (24.6)

 High

34,708 (41.0)

629 (35.4)

34,618 (42.7)

792 (37.0)

AOPE, n (%)

 APOE e4 non-carrier

61,557 (72.8)

746 (42%)

58,364 (72.0)

1020 (47.7)

 APOE e4 carrier

23,053 (27.2)

1032 (58.0)

22,714 (28.0)

1119 (52.3)

  1. APOE, apolipoprotein; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); HDL, high density lipoprotein; LDL, low density lipoprotein; SD, standard deviation; TC, cholesterol